Regulation of Ferroptosis in Lung Adenocarcinoma

Lung adenocarcinoma (LUAD) is the most common lung cancer, which accounts for about 35–40% of all lung cancer patients. Despite therapeutic advancements in recent years, the overall survival time of LUAD patients still remains poor, especially KRAS mutant LUAD. Therefore, it is necessary to further...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xiangyun, Li, Xiaohe, Hu, Shuming, Cheng, Jinke, Cai, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572737/
https://www.ncbi.nlm.nih.gov/pubmed/37834062
http://dx.doi.org/10.3390/ijms241914614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572737/
https://www.ncbi.nlm.nih.gov/pubmed/37834062
http://dx.doi.org/10.3390/ijms241914614

Ejemplares similares